HLA association of amoxicillin-clavulanate-induced hepatitis

Gastroenterology

Volumn 117, Issue 5, 1999, Pages 1181-1186

  Hautekeete, M L ^a   Horsmans, Y ^a   Van Waeyenberge, C ^a   Demanet, C ^a   Henrion, J ^a   Verbist, L ^a   Brenard, R ^a   Sempoux, C ^a   Michielsen, P P ^a   Yap, P S H ^a   Rahier, J ^a   Geubel, A P ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HAPLOTYPE; HLA SYSTEM; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; LIVER HISTOLOGY; MALE; PRIORITY JOURNAL; TOXIC HEPATITIS;

EID: 0032738987     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70404-X     Document Type: Article

References (26)

1. D. Pessayre Mechanisms of drug-induced hepatic injury 2nd ed BHCh Stricker Drug-induced hepatic injury 1992 Elsevier Amsterdam 23 49
2. BHCh Stricker Drug-induced hepatic injury 2nd ed 1992 Elsevier Amsterdam
3. D Larrey T Vial A Micaleff G Babany M Morichau-Beauchant H Michel JP. Benhamou Hepatitis associated with amoxycillin-clavulanic acid: combination report of 15 cases Gut 33 1992 368 371
4. R Olsson BE Wiholm C Sand L Zettergren R Hultcranz M. Myrhed Liver damage from flucloxacillin, cloxacillin and dicloxacillin J Hepatol 15 1992 154 161
5. LA Garcia Rodriguez BH Stricker HJ. Zimmerman Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid Arch Intern Med 156 1996 1327 1332
6. BHCh Stricker APR Block FHJ Claas GE Van Parys VJ. Desmet Hepatic injury associated with the use of nitrofurans: a clinico-pathological study of 52 reported cases Hepatology 8 1988 599 606
7. D Larrey A Berson F Habersetzer M Tinel A Castot G Babany P Letteron E Freneaux J Loeper P Dansette D. Pessayre Genetic predisposition to drug hepatotoxicity: role in hepatitis caused by amineptine, a tricyclic antidepressant Hepatology 10 1989 168 173
8. G Farrell D Prendergast M. Murray Halothane hepatitis: detection of a constitutional susceptibility factor N Engl J Med 313 1985 1310 1314
9. OE Eade D Grice EL Krawitt J Trowell R Albertini H Festenstein R. Wright HLA A and B locus antigens in patients with unexplained hepatitis following halothane anesthesia Tissue Antigens 17 1981 428 432
10. A Berson E Freneaux D Larrey V Lepage C Douay C Mallet B Fromenty JP Benhamou D. Pessayre Possible role of HLA in hepatotoxicity: an exploratory study in 71 patients with drug-induced idiosyncratic hepatitis J Hepatol 20 1994 336 342
11. EA Pariente A Hamoud D Goldfain JP Latrive J Gislon P Cassan T Morin JL Staub JP Ramain JL Bertrand J Denis J Lafon D Labayle F Druart A Blanchi J Kammerer Hépatites à la clométacine (Dupérant®): étude rétrospective de 30 cas. Un modèle d'hépatite auto-immune médicamenteuse? Gastroenterol Clin Biol 13 1989 769 774
12. P Donaldson D Doherty J Underhill R. Williams The molecular genetics of autoimmune liver disease Hepatology 20 1994 225 239
13. KR Reddy P Brillant ER Schiff Amoxicillin-clavulanate potassium–associated cholestasis Gastroenterology 96 1989 1135 1141
14. FS Wong J Ryan P Dabkowski FJ Dudley RB Sewell RA. Smallwood Augmentin-induced jaundice Med J Aust 154 1991 698 701
15. ML Hautekeete R Brenard Y Horsmans J Henrion L Verbist G Derue P Druez M Omar M Kockx H Hubens I Haber J Rahier AP. Geubel Liver injury related to amoxycillin-clavulanic acid: interlobular bile duct lesions and extrahepatic manifestations J Hepatol 22 1995 71 77
16. C. Benichou Criteria of drug-induced liver disorders: report of an international consensus meeting J Hepatol 11 1990 272 276
17. PP Michielsen MJ VanOutryve EA VanMarck MH DeMaeyer PA Pelckmans YM. VanMaercke Amoxycillin/clavulanic acid induced cholestasis J Hepatol 11 1990 392
18. I Buyse R Decorte M Baens H Cuppens G Semana MP Emonds P Marynen JJ. Cassiman Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization Tissue Antigens 41 1993 1 14
19. PL Terasaki DW. Gjertson HLA 1997. Population studies 1st ed 1997 UCLA Press Los Angeles 171 426
20. MM Manns M Krüger Immunogenetics of chronic liver diseases Gastroenterology 106 1994 1676 1697
21. H Miyamori Y Kato K Kobayashi N. Hattori HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis Digestion 26 1983 213 217
22. PT Donaldson JM Farrant ML Wilkinson K Hayliar BC Portmann R. Williams Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis Hepatology 13 1991 129 133
23. JM Farrant DG Doherty PT Donaldson RW Vaughan KM Hayllar KI Welsh AL Eddleston R Williams Amino acid substitutions at position 38 of the DRβ polypeptide confer susceptibility and protection from primary sclerosing cholangitis Hepatology 16 1992 390 395
24. NG Ryley KA Fleming RWG. Chapman Focal destructive cholangiopathy associated with amoxycillin/clavulanic acid (Augmentin) J Hepatol 23 1995 278 282
25. GC Bolton GD Allen BE Davies C Filer DJ. Jeffery The disposition of clavulanic acid in man Xenobiotica 16 1986 853 863
26. GC Bolton GD Allen CW Filer DJ. Jeffery Absorption, metabolism and excretion studies on clavulanic acid in the rat and dog Xenobiotica 14 1984 483 490